Mentice AB (SE:MNTC)
:MNTC
MNTC Stock Chart & Stats
kr13.40
kr0.70(3.37%)
At close: 4:00 PM EST
kr13.40
kr0.70(3.37%)
Day’s Range― - ―
52-Week Rangekr8.50 - kr21.06
Previous CloseN/A
Volume190.00
Average Volume (3M)19.32K
Market Cap
kr376.88M
Enterprise Valuekr369.66M
Total Cash (Recent Filing)kr33.38M
Total Debt (Recent Filing)kr26.15M
Price to Earnings (P/E)―
Beta0.84
Next Earnings
May 07, 2026EPS Estimate
-0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.46
Shares Outstanding28,125,734
10 Day Avg. Volume26,429
30 Day Avg. Volume19,315
Financial Highlights & Ratios
PEG Ratio-0.19
Price to Book (P/B)2.71
Price to Sales (P/S)1.34
P/FCF Ratio-14.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.09
Revenue Forecast (FY)kr308.01M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue StreamsMentice's revenue mix includes system sales, software licenses/subscriptions, maintenance and add-on modules, which support recurring and contracted revenue streams. That mix yields more predictable cash inflows, customer lock-in via installed bases, and upsell pathways with device partners, aiding durable revenue visibility over months.
Niche Clinical Simulation MarketMentice operates in a specialized simulation niche for endovascular and minimally invasive image-guided procedures. Structural growth in minimally invasive interventions and ongoing clinical training requirements create durable demand for simulation products, promoting sticky hospital and device-manufacturer relationships and long adoption cycles.
Serviceable Balance SheetThe balance sheet is described as serviceable with relatively modest leverage and sizeable equity, providing a financial buffer. This headroom supports continued product development and commercialization efforts, reduces immediate solvency risk, and preserves strategic optionality while the business works toward sustained profitability.
Bears Say
Persistent Losses & Margin VolatilityProfitability is weak and volatile, with continued net losses and a sharp deterioration in 2025 that includes negative gross profit. Negative gross profit indicates structural cost or pricing mismatches that impede the company's ability to convert revenue into sustainable earnings and to generate positive returns on invested capital over the medium term.
Renewed Cash BurnCash generation is inconsistent and turned materially negative in 2025 for both operating and free cash flow. Renewed cash burn heightens reliance on external financing, increases dilution or leverage risk, and constrains the firm's ability to fund R&D, sales expansion and capital deployment needed to scale sustainably.
Rising Leverage In 2025Debt increased in 2025 and the debt-to-equity ratio rose meaningfully versus prior years, reducing financial flexibility. Rising leverage increases interest burden and refinancing risk, which is particularly concerning given persistent losses and weak cash flow, and can limit the company's ability to invest or weather further operational setbacks.
Mentice AB News
MNTC FAQ
What was Mentice AB’s price range in the past 12 months?
Mentice AB lowest stock price was kr8.50 and its highest was kr21.06 in the past 12 months.
What is Mentice AB’s market cap?
Mentice AB’s market cap is kr376.88M.
When is Mentice AB’s upcoming earnings report date?
Mentice AB’s upcoming earnings report date is May 07, 2026 which is in 34 days.
How were Mentice AB’s earnings last quarter?
Mentice AB released its earnings results on Feb 26, 2026. The company reported kr0.46 earnings per share for the quarter, beating the consensus estimate of kr0.058 by kr0.402.
Is Mentice AB overvalued?
According to Wall Street analysts Mentice AB’s price is currently Overvalued.
Does Mentice AB pay dividends?
Mentice AB does not currently pay dividends.
What is Mentice AB’s EPS estimate?
Mentice AB’s EPS estimate is -0.19.
How many shares outstanding does Mentice AB have?
Mentice AB has 28,125,734 shares outstanding.
What happened to Mentice AB’s price movement after its last earnings report?
Mentice AB reported an EPS of kr0.46 in its last earnings report, beating expectations of kr0.058. Following the earnings report the stock price went up 10.357%.
Which hedge fund is a major shareholder of Mentice AB?
Currently, no hedge funds are holding shares in SE:MNTC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mentice AB
Mentice AB (publ) provides endovascular simulation solutions to teaching entities, healthcare systems, and medical device manufacturers. The company operates through Medical Device Industry, Healthcare Systems, and Strategic Alliances segments. It provides software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced and essentials, coronary intermediate, left atrial appendage occlusion, neurovascular coiling and thrombectomy, peripheral angiography, prostatic artery embolization, radiation safety, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, peripheral angiography, and vascular trauma and cardiac rhythm management, as well as supports interventionalists to transition from transfemoral to transradial access. The company also offers medical simulators for endovascular therapies, and simulator accessories and extensions for endovascular therapies; silicone vasculature for endovascular simulation; cardiac and vascular flow systems; neurovascular flow systems; mentice right heart cath app, a mobile solution for an interactive real-time exploration into the right heart catheterization procedure; mentice live learning center, a remote learning with its VIST G endovascular simulation platform. Its products are used to educate, train, and enhance the practitioners in skills. The company operates in Europe, the Middle East, and Africa; Asia Pacific region; and the Americas. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
Technical Analysis
Clinical Laserthermia Systems AB Class B
―
Bactiguard Holding AB
―
C-Rad AB Class B
―
Acarix AB
―
BrainCool AB
―